Drugs / Microbiota Transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01868373 | Feb 2013 → Feb 2035 expected | Clostridium difficile colitis | Baylor College of Medicine | Enrolling by invitation | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Microbiota Transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01868373 ↗ |
| Known as | FMT | “Biological: Microbiota Transplantation (FMT)” NCT01868373 ↗ |
| Action | Restore | “the introduction of microbes from a healthy donor should allow for the restoration of a normal microbial community in the diseased host” NCT01868373 ↗ |
| Modality | Other / unclassified | “bacterial suspension (microbiota transplantation)” NCT01868373 ↗ |
| Route | Other | “The 200 mL bacterial suspension will then be administered into the small intestine using an Olympus ultra-slim gastro-duodenoscope.” NCT01868373 ↗ |